Healthcare sector projects by Rusan Pharma Ltd in Kandla
Project Information
7137
Rusan Pharma Ltd
Rusan Pharma, which specialises in de-addiction and pain management products, is investing Rs 100 crore in a research and development centre and a manufacturing unit in Kandla. A clinical research organisation too is being set up as a part of its expansion plan.
Rusan Pharma said with the fresh investment, it will focus on research and manufacture of de-addiction and pain management drugs for domestic market and export and aims to double turnover to Rs 600 crore by 2018.
The company plans to manufacture transdermal patches at Kandla. Rusan Pharma exports products to Europe, Russia, South Africa, South East Asia and plans to expand exports to the US and Canada.
Project Value
INR 100 Crore /-
Investment Approved
Kandla
Gujarat
India
Healthcare
Disclaimer :
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
